We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
-12.52%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$6.47B
AUM Growth
-$1.7B
(-21%)
Cap. Flow
-$612M
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
39.4%
Holding
758
New
244
Increased
84
Reduced
79
Closed
303
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$69.4M |
| 2 |
Morgan Stanley
MS
|
+$50.7M |
| 3 |
Citigroup
C
|
+$50.1M |
| 4 |
Amazon
AMZN
|
+$49.8M |
| 5 |
Warner Bros
WBD
|
+$42.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$284M |
| 2 |
T-Mobile US
TMUS
|
+$161M |
| 3 |
Qualcomm
QCOM
|
+$151M |
| 4 |
Micron Technology
MU
|
+$149M |
| 5 |
Alibaba
BABA
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.55% |
| 2 | Communication Services | 6.92% |
| 3 | Consumer Discretionary | 5.57% |
| 4 | Utilities | 3.44% |
| 5 | Financials | 2.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
PUT
Thermo Fisher Scientific
TMO
$222B
| $5.43M | 0.08% |
+10,000
| New | +$5.5M |
|
152
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $5.41M | 0.08% |
+75,000
| New | +$5.63M |
|
153
Blackrock
BLK
$178B
| $5.35M | 0.08% |
+8,785
| New | +$5.72M |
|
154
PUT
Alaska Air
ALK
$5.4B
| $5.35M | 0.08% |
+133,500
| New | +$6.52M |
|
155
AnaptysBio
ANAB
$1.72B
| $5.34M | 0.08% |
263,208
+55,708
| +27% | +$1.23M |
|
156
Fortinet
FTNT
$119B
| $5.34M | 0.08% |
94,386
+44,226
| +88% | +$2.63M |
|
157
Alaunos Therapeutics
TCRT
$4.84M
| $5.32M | 0.08% |
+28,595
| New | +$2.73M |
|
158
Home Depot
HD
$356B
| $5.29M | 0.08% |
19,288
-32,320
| -63% | -$9.54M |
|
159
PUT
JPMorgan Chase
JPM
$956B
| $5.07M | 0.08% |
45,000
+44,700
| +14,900% | +$5.54M |
|
160
CALL
Bausch Health
BHC
$2.32B
| $5.05M | 0.08% |
603,600
-990,000
| -62% | -$13.8M |
|
161
Biomea Fusion
BMEA
$95M
| $5.03M | 0.08% |
+420,149
| New | +$2.46M |
|
|
162
PUT
Fortinet
FTNT
$119B
| $4.95M | 0.08% |
+87,500
| New | +$5.2M |
|
163
CALL
FedEx
FDX
$77B
| $4.9M | 0.08% |
21,600
-15,000
| -41% | -$3.2M |
|
164
Crown Holdings
CCK
$13.1B
| $4.83M | 0.07% |
+52,426
| New | +$5.6M |
|
165
NXP Semiconductors
NXPI
$60.4B
| $4.82M | 0.07% |
+32,526
| New | +$5.65M |
|
166
PUT
TJX Companies
TJX
$174B
| $4.75M | 0.07% |
+85,000
| New | +$5.14M |
|
167
PUT
Expedia Group
EXPE
$38.4B
| $4.74M | 0.07% |
+50,000
| New | +$7.08M |
|
168
PUT
Zimmer Biomet
ZBH
$18.5B
| $4.73M | 0.07% |
+45,000
| New | +$5.34M |
|
|
DCPH
169
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.71M | 0.07% |
358,380
-100,910
| -22% | -$1.11M |
|
|
CBAY
170
DELISTED
Cymabay Therapeutics
CBAY
| $4.65M | 0.07% |
+1,575,269
| New | +$3.76M |
|
|
KALV
171
DELISTED
KalVista Pharmaceuticals
KALV
| $4.63M | 0.07% |
470,000
| – | – |
|
172
CALL
iShares US Real Estate ETF
IYR
$4.5B
| $4.6M | 0.07% |
+50,000
| New | +$4.99M |
|
|
173
PUT
iShares US Real Estate ETF
IYR
$4.5B
| $4.6M | 0.07% |
+50,000
| New | +$4.99M |
|
174
Goldman Sachs
GS
$301B
| $4.57M | 0.07% |
15,387
-21,387
| -58% | -$6.66M |
|
175
PUT
Halliburton
HAL
$28.1B
| $4.38M | 0.07% |
+139,800
| New | +$5.21M |
|
Similar funds
AFM
GCP
LCM
MAP
MA
NSAM
ABI
OCM
Laurion Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Laurion Capital Management held 758 positions worth $6.47B, down 21% from $8.17B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Laurion Capital Management withdrew a net $612M in Q2 2022, closing 303 positions and reducing 79 holdings. Its most notable exit was International Flavors & Fragrances, an estimated $284M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Laurion Capital Management opened a new position in Morgan Stanley worth $47M.
- Laurion Capital Management's largest Q2 2022 buy was Morgan Stanley: 618,580 shares worth $47M.
- Laurion Capital Management added most to Lowe's Companies in Q2 2022, an estimated $69.4M increase.
- Laurion Capital Management's biggest Q2 2022 reduction was T-Mobile US, cutting an estimated $161M.
- Laurion Capital Management fully exited International Flavors & Fragrances in Q2 2022, selling an estimated $284M.
- Laurion Capital Management's ten largest holdings make up 39% of its $6.47B portfolio in Q2 2022.
- Laurion Capital Management opened 244 new positions and closed 303 in Q2 2022.
- Laurion Capital Management's portfolio value fell 21% quarter-over-quarter to $6.47B.
Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.